Davis Jm

1.2k total citations
84 papers, 924 citations indexed

About

Davis Jm is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Davis Jm has authored 84 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Psychiatry and Mental health and 7 papers in Surgery. Recurrent topics in Davis Jm's work include Occupational and environmental lung diseases (9 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Body Composition Measurement Techniques (3 papers). Davis Jm is often cited by papers focused on Occupational and environmental lung diseases (9 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Body Composition Measurement Techniques (3 papers). Davis Jm collaborates with scholars based in United States, United Kingdom and Japan. Davis Jm's co-authors include Smith Rc, Moore Fd, Janowsky Ds, M. B. Grisham, Stephen Brand, Don Hedeker, H. Dekirmenjian, Dominick Gadaleta, J. I. Javaid and Ken Donaldson and has published in prestigious journals such as PubMed, Nova Science Publishers (Nova Science Publishers, Inc.) and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Davis Jm

79 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davis Jm United States 17 201 182 113 103 98 84 924
I. Macquin‐Mavier France 18 313 1.6× 109 0.6× 174 1.5× 149 1.4× 251 2.6× 38 953
H. Kollegger Austria 17 51 0.3× 146 0.8× 141 1.2× 132 1.3× 122 1.2× 35 1.3k
Robert J. Baumann United States 21 147 0.7× 557 3.1× 184 1.6× 149 1.4× 134 1.4× 74 1.4k
Michael Brainin Austria 7 86 0.4× 171 0.9× 213 1.9× 118 1.1× 160 1.6× 11 1.2k
Stig Hansen United Kingdom 15 40 0.2× 146 0.8× 121 1.1× 67 0.7× 147 1.5× 25 954
Robert C. Woody United States 17 47 0.2× 194 1.1× 183 1.6× 69 0.7× 157 1.6× 45 849
Cemal Özcan Türkiye 19 104 0.5× 216 1.2× 118 1.0× 43 0.4× 120 1.2× 90 1.2k
Céline Faure France 21 75 0.4× 106 0.6× 218 1.9× 148 1.4× 156 1.6× 71 1.4k
S. Andersson Sweden 16 55 0.3× 87 0.5× 123 1.1× 113 1.1× 260 2.7× 23 1.3k
R. Lane United Kingdom 22 401 2.0× 315 1.7× 340 3.0× 220 2.1× 219 2.2× 59 1.7k

Countries citing papers authored by Davis Jm

Since Specialization
Citations

This map shows the geographic impact of Davis Jm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis Jm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis Jm more than expected).

Fields of papers citing papers by Davis Jm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davis Jm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis Jm. The network helps show where Davis Jm may publish in the future.

Co-authorship network of co-authors of Davis Jm

This figure shows the co-authorship network connecting the top 25 collaborators of Davis Jm. A scholar is included among the top collaborators of Davis Jm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davis Jm. Davis Jm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pizzo, Giuseppe, et al.. (2007). Pharmacotherapies for smoking cessation. Nova Science Publishers (Nova Science Publishers, Inc.). 5–40.
2.
Brand, Stephen, et al.. (1997). Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis.. PubMed. 282(3). 1615–22. 93 indexed citations
3.
Jm, Davis, et al.. (1992). Physiologic and perceptual responses to exercise on a new cycle ergometer.. PubMed. 17(1). 56–9. 6 indexed citations
4.
Jm, Davis, et al.. (1991). Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets.. PubMed. 27(3). 255–61. 12 indexed citations
5.
Jm, Davis. (1990). Risk assessment of the developmental neurotoxicity of lead.. PubMed. 11(2). 285–91. 37 indexed citations
6.
Ryu, Tomoki, et al.. (1990). Dose-dependent platelet stimulation and inhibition induced by anti-PIA1 IgG.. PubMed. 116(1). 91–9. 5 indexed citations
7.
Jm, Davis & Joseph E. Comaty. (1988). Legal aspects of tardive dyskinesia.. PubMed. 14 Spec No. 257–61. 5 indexed citations
8.
Jm, Davis, et al.. (1985). Peritoneovenous shunting for cirrhotic versus malignant ascites.. PubMed. 161(3). 204–8. 7 indexed citations
9.
Jm, Davis, et al.. (1985). Haloperidol plasma levels and clinical response: basic concepts and clinical data.. PubMed. 21(1). 48–51. 17 indexed citations
10.
Jm, Davis, et al.. (1982). Interrelationship between proximal tubular hydrodynamics and tubuloglomerular feedback in the rat kidney.. PubMed. 12. S193–7. 6 indexed citations
11.
Osborne, Michael T., et al.. (1982). Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients.. PubMed. 17(5). 627–9. 17 indexed citations
12.
Jm, Davis, et al.. (1981). Perstimulatory adaptation as measured by reaction time: asymmetry between 400 and 500 kc/s.. PubMed. 21(1). 13–6. 1 indexed citations
13.
Jm, Davis, et al.. (1980). Use of common morphemes by hearing-impaired children exposed to a system of manual English.. PubMed. 20(1). 57–69. 6 indexed citations
14.
Dorus, Elizabeth, et al.. (1979). Low platelet monoamine oxidase activity, high red blood cell lithium ratio, and affective disorders: a multivariate assessment of genetic vulnerability to affective disorders.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(6). 989–93. 5 indexed citations
15.
Ds, Janowsky, et al.. (1979). Adrenergic and cholinergic drugs as episode and vulnerability markers of affective disorders and schizophrenia.. PubMed. 15(1). 33–4. 5 indexed citations
16.
Dekirmenjian, H., et al.. (1978). Phenothiazine red cell levels and clinical response [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(3). 27–29. 18 indexed citations
17.
Narasimhachari, N., et al.. (1978). Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.. PubMed. 2(4). 337–42. 1 indexed citations
18.
Jm, Davis. (1976). Structural variations between pleural and peritoneal mesotheliomas produced in rats by the injection of crocidolite asbestos.. PubMed. 21(2). 199–210. 7 indexed citations
19.
Jm, Davis, et al.. (1975). The effect of quartz and other non-coal dusts in coalworkers' pneumoconiosis. Part II. Lung autopsy study.. PubMed. 4 Pt 2. 691–702. 13 indexed citations
20.
Jm, Davis, et al.. (1972). Guanethidine antagonism by antipsychotic drugs.. PubMed. 65(7). 620–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026